Comparative mortality in anaesthesia.

the role in clinical anesthesia. Anesthesiology 1991; 74: 581±605 16 Angel A, Majeed AB. Alterations of `sleeping time' in the rat induced by drugs which modulate central monoaminergic systems. Br J Anaesth 1990; 64: 594±600 17 Mason ST, Angel A. Brain noradrenaline and anaesthesia: further characterization of the beta-receptor. Neuropharmacology 1983; 22: 1065±9 18 Smart D. Orexins: a new family of neuropeptides. Br J Anaesth1999; 83: 695±7 19 Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell ®ring and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911±6 20 Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365±76 21 Kubota K, Hirota K, Yoshida H, et al. Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats. GABAA receptor activator vs NMDA receptor inhibitor. Psychopharmacology 1999; 146: 335±8 22 Kubota T, Anzawa N, Hirota K, Yoshida H, Matsuki A. Effects of ketamine and pentobarbital on norepinephrine release from the median frontal cortex in rats. Can J Anaesth 1999; 46: 388±92 23 Yoshida H, Kushikata T, Kubota T, Hirota K, Ishihara H, Matsuki A. Increased norepinephrine release from anterior and posterior hypothalamus following xenon inhalation. Can J Anesth 2001; 48: 651±5 24 Alam MN, McGinity D, Szymusiak R. Neuronal discharge of preoptic/anterior hypothalamus thermosensitive neurons: relation to NREM sleep. Am J Physiol 1995; 269: R1240±9 25 Kubota K, Hirota K, Anzawa N, Yoshida H, Takahashi S, Matsuki A. Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats. Brain Res 1999; 840: 175±8